Folic Acid, Vitamin B6, Vitamin B12 and Riboflavin: study protocols
21 study groups took Folic Acid together with Vitamin B6, Vitamin B12 and Riboflavin. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Folic Acid
21 study groups in 17 studies say how much Folic Acid participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 250 mcg to 500 mcg, 43% of 21 study groups.
| Daily dose | Study groups |
|---|---|
| 100 mcg to 250 mcg | 4 |
| 250 mcg to 500 mcg | 9 |
| 500 mcg to 1 mg | 5 |
| 1 mg to 2.5 mg | 1 |
| 2.5 mg to 5 mg | 2 |
Dose per serving from research: Vitamin B6
21 study groups in 17 studies say how much Vitamin B6 participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 mg to 2.5 mg, 29% of 21 study groups.
| Daily dose | Study groups |
|---|---|
| 250 mcg to 500 mcg | 3 |
| 500 mcg to 1 mg | 1 |
| 1 mg to 2.5 mg | 6 |
| 2.5 mg to 5 mg | 4 |
| 5 mg to 10 mg | 2 |
| 10 mg to 25 mg | 2 |
| 25 mg to 50 mg | 3 |
Dose per serving from research: Vitamin B12
21 study groups in 17 studies say how much Vitamin B12 participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 2.5 mcg to 5 mcg, 29% of 21 study groups.
| Daily dose | Study groups |
|---|---|
| 0.25 mcg to 0.5 mcg | 2 |
| 0.5 mcg to 1 mcg | 1 |
| 1 mcg to 2.5 mcg | 2 |
| 2.5 mcg to 5 mcg | 6 |
| 5 mcg to 10 mcg | 5 |
| 10 mcg to 25 mcg | 0 |
| 25 mcg to 50 mcg | 2 |
| 50 mcg to 100 mcg | 0 |
| 100 mcg to 250 mcg | 0 |
| 250 mcg to 500 mcg | 3 |
Dose per serving from research: Riboflavin
21 study groups in 17 studies say how much Riboflavin participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 mg to 2.5 mg, 43% of 21 study groups.
| Daily dose | Study groups |
|---|---|
| 100 mcg to 250 mcg | 2 |
| 250 mcg to 500 mcg | 1 |
| 500 mcg to 1 mg | 0 |
| 1 mg to 2.5 mg | 9 |
| 2.5 mg to 5 mg | 6 |
| 5 mg to 10 mg | 1 |
| 10 mg to 25 mg | 2 |
Commonly used together
18 of 21 study groups took Folic Acid, Vitamin B6, Vitamin B12 and Riboflavin with something else. Shown: what 3 or more different studies gave. The 10 most common of 11.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Vitamin E | 12 |
| Thiamine | 11 |
| Vitamin C | 11 |
| Zinc | 10 |
| Iron | 9 |
| Vitamin A | 9 |
| Vitamin D | 9 |
| Niacin | 8 |
| Copper | 7 |
| Iodine | 7 |
21 study groups
| Study | ||||||
|---|---|---|---|---|---|---|
| Modifying effects of maternal Hb concentration on infant birth weight in women receiving prenatal iron-containing supplements: a randomised controlled trial 2016 · MMN group · Pregnant women aged at least 20 years, nulliparous, with Hb concentration ≥100 g/L and enrolled before 20 weeks of gestation | 400 mcg | 1.9 mg | 2.6 mcg | 1.4 mg | — | — |
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Multiple micronutrients · Pregnant women in rural Nepal | 400 mcg | 2.2 mg | 2.6 mcg | 1.8 mg | — | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Multivitamin plus vitamin A · HIV-positive pregnant Tanzanian women | 800 mcg | 25 mg | 50 mcg | 20 mg | — | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Multivitamin without vitamin A · HIV-positive pregnant Tanzanian women | 800 mcg | 25 mg | 50 mcg | 20 mg | — | — |
| Predictors of adherence to micronutrient supplementation before and during pregnancy in Vietnam 2017 · MM (multiple micronutrients) preconception group · Women of reproductive age in Vietnam intending to become pregnant | 400 mcg | 271 mcg | 0.371 mcg | 200 mcg | 54 weeks | 1,469 |
| Assessing the adherence and acceptability to iron and folic acid compared with multiple micronutrient supplements during pregnancy: a cluster-randomized noninferiority trial in Cambodia 2025 · MMS-180 · Healthy pregnant individuals aged 18–45 years, in the first 14 weeks of a low-risk singleton pregnancy | 400 mcg | 1.9 mg | 2.6 mcg | 1.4 mg | 180 days | 516 |
| Assessing the adherence and acceptability to iron and folic acid compared with multiple micronutrient supplements during pregnancy: a cluster-randomized noninferiority trial in Cambodia 2025 · MMS-90 · Healthy pregnant individuals aged 18–45 years, in the first 14 weeks of a low-risk singleton pregnancy | 400 mcg | 1.9 mg | 2.6 mcg | 1.4 mg | 180 days | 515 |
| Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation 2011 · Group MVB · Patients with type 2 diabetes | 1 mg | 10 mg | 10 mcg | 10 mg | 120 days | — |
| Three-month B vitamin supplementation in pre-school children affects folate status and homocysteine, but not cognitive performance 2014 · B vitamin supplementation group · Healthy preschool children selected for low urinary folate-status ranking | 220 mcg | 730 mcg | 1.2 mcg | 1.1 mg | 90 days | — |
| A 2-Year Randomized Controlled Trial With Low-Dose B-Vitamin Supplementation Shows Benefits on Bone Mineral Density in Adults With Lower B12 Status 2022 · B-vitamin treatment · Community-dwelling adults aged 50 years or older; men and women; no specific diagnosed condition, and not currently taking B-vitamin supplements at screening | 200 mcg | 10 mg | 10 mcg | 5 mg | 2 years | 103 |
| Impact of Preconception Micronutrient Supplementation on Anemia and Iron Status during Pregnancy and Postpartum: A Randomized Controlled Trial in Rural Vietnam 2016 · Multiple micronutrients (MM) · Women aged 18–40 planning pregnancy in rural Vietnam; no specific diagnosed condition required | 400 mcg | 271 mcg | 0.371 mcg | 200 mcg | 56 weeks | 508 |
| Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial 2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception | 400 mcg | 2.6 mg | 5.2 mcg | 1.8 mg | — | 870 |
| Daily supplementation of a multiple micronutrient powder improves folate but not thiamine, riboflavin, or vitamin B(12) status among young Laotian children: a randomized controlled trial 2022 · micronutrient powder group (MNP) · Children aged 6–23 months in rural Lao PDR; no disease-based selection, with high prevalence of undernutrition and micronutrient deficiencies | 150 mcg | 500 mcg | 0.9 mcg | 500 mcg | 36 weeks | 130 |
| A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels 2019 · Natural vitamin B complex (group N) · Healthy adults; age range and sex not specified | 690 mcg | 3.38 mg | 8.85 mcg | 3.98 mg | 6 weeks | 30 |
| A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels 2019 · Synthetic vitamin B complex (group S) · Healthy adults; age range and sex not specified | 690 mcg | 3.38 mg | 8.85 mcg | 3.98 mg | 6 weeks | 30 |
| Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial 2006 · B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset | 5 mg | 50 mg | 400 mcg | 5 mg | 2 weeks | 24 |
| Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial 2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset | 5 mg | 50 mg | 400 mcg | 5 mg | 2 weeks | 24 |
| A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia 2019 · UNIMMAP tablet · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population | 400 mcg | 1.9 mg | 2.6 mcg | 1.4 mg | 12 weeks | 105 |
| Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial 2016 · Normocis 400® group · Adults with stage 1 essential hypertension and hyper-homocysteinemia (HCys ≥15 μmol/L), without a history of cardiovascular or cerebrovascular disease; mean age 62.8 years, 63.5% male | 400 mcg | 3 mg | 5 mcg | 2.4 mg | 60 days | 52 |
| Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour 2002 · Folic acid, riboflavin, and vitamin B12 with vitamin B6 · Adults with stable coronary artery disease; mean age 60.1 years; 29.8% women | 2.5 mg | 50 mg | 400 mcg | 5 mg | 12 weeks | — |
| Effects of mixed dietary supplements on total plasma homocysteine concentrations (tHcy): a randomized, double-blind, placebo-controlled trial 2012 · supplement group · hospitalized, acutely ill older patients recovering from acute illness; sex and age range not stated | 200 mcg | 1.4 mg | 1.5 mcg | 1.3 mg | 6 weeks | — |